• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力疗法治疗息肉状脉络膜血管病变的 3 年随访结果。

Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.

机构信息

Department of Ophthalmology, Nihon University Surugadai Hospital, Tokyo, Japan.

出版信息

Jpn J Ophthalmol. 2011 Jan;55(1):39-44. doi: 10.1007/s10384-010-0886-x. Epub 2011 Feb 18.

DOI:10.1007/s10384-010-0886-x
PMID:21331691
Abstract

PURPOSE

To evaluate the visual outcomes and changes in abnormal vascular networks and polypoidal lesions of polypoidal choroidal vasculopathy (PCV) 3 years after photodynamic therapy (PDT).

METHODS

We studied 43 eyes of 43 patients with PCV for 3 years. Fundus appearance, fluorescein angiography (FA) and indocyanine green angiography (IA) findings, and visual acuity (VA) before the initial PDT were compared with those 3 months, 1 year, 2 years, and 3 years after treatment.

RESULTS

In 24 of the 43 eyes, enlargement of the abnormal vascular network continued in a manner similar to that before PDT on IA; in eight eyes, transformation into polypoidal choroidal neovascularization (CNV) with enlargement was detected; and two eyes had the appearance of classic CNV on FA. Polypoidal lesions recurred at 3 years in 33 of the 43 eyes (77%). Mean VA (logarithm of the minimum angle of resolution) of all 43 eyes decreased to below baseline at 3 years after the initial PDT. This decrease can be explained by foveal atrophy after absorption of recurrent hemorrhagic or exudative detachment.

CONCLUSION

Long-term visual outcomes were not good owing to the high frequency of recurrent polypoidal lesions, as well as enlargement and neovascular changes involving abnormal vascular networks.

摘要

目的

评估 3 年后光动力疗法(PDT)后息肉状脉络膜血管病变(PCV)异常血管网络和息肉样病变的视觉结果和变化。

方法

我们对 43 例 PCV 患者的 43 只眼进行了 3 年的研究。比较了初始 PDT 前、治疗后 3 个月、1 年、2 年和 3 年的眼底表现、荧光素血管造影(FA)和吲哚青绿血管造影(IA)结果以及视力(VA)。

结果

在 43 只眼中的 24 只眼中,IA 上异常血管网络的扩大以类似于 PDT 前的方式继续;在 8 只眼中,检测到扩大的息肉状脉络膜新生血管化(CNV)的转化;2 只眼 FA 上出现典型 CNV 的外观。在 43 只眼中,33 只眼(77%)在 3 年内息肉样病变复发。所有 43 只眼的平均 VA(最小分辨角对数)在初始 PDT 后 3 年降至基线以下。这种下降可以用复发性出血或渗出性脱离吸收后的黄斑萎缩来解释。

结论

由于息肉样病变的高复发率以及异常血管网络的扩大和新生血管变化,长期视觉结果不佳。

相似文献

1
Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.光动力疗法治疗息肉状脉络膜血管病变的 3 年随访结果。
Jpn J Ophthalmol. 2011 Jan;55(1):39-44. doi: 10.1007/s10384-010-0886-x. Epub 2011 Feb 18.
2
Intravitreal ranibizumab combined with verteporfin photodynamic therapy for treating polypoidal choroidal vasculopathy.眼内雷珠单抗联合维替泊芬光动力疗法治疗息肉状脉络膜血管病变。
Retina. 2011 Jul-Aug;31(7):1287-93. doi: 10.1097/IAE.0b013e3182003ccd.
3
Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.眼内雷珠单抗联合或不联合光动力疗法治疗有症状的息肉状脉络膜血管病变。
Retina. 2011 Sep;31(8):1581-8. doi: 10.1097/IAE.0b013e31820d3f3f.
4
Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy.吲哚菁绿血管造影:息肉状脉络膜血管病变的光动力治疗引导
Am J Ophthalmol. 2007 Jul;144(1):7-14. doi: 10.1016/j.ajo.2007.03.014. Epub 2007 Apr 30.
5
Treatment of polypoidal choroidal vasculopathy with photodynamic therapy combined with intravitreal injections of ranibizumab.光动力疗法联合玻璃体内注射雷珠单抗治疗息肉状脉络膜血管病变。
Am J Ophthalmol. 2012 Jan;153(1):68-80.e1. doi: 10.1016/j.ajo.2011.07.001. Epub 2011 Sep 9.
6
[Polypoidal choroidal vasculopathy].[息肉样脉络膜血管病变]
Nippon Ganka Gakkai Zasshi. 2012 Mar;116(3):200-31; discussion 232. doi: 10.4264/numa.71.282.
7
Factors influencing visual outcome of polypoidal choroidal vasculopathy one year after photodynamic therapy.影响光动力疗法治疗后一年息肉样脉络膜血管病变患者视力预后的因素。
Graefes Arch Clin Exp Ophthalmol. 2010 Sep;248(9):1233-9. doi: 10.1007/s00417-010-1365-2. Epub 2010 Mar 30.
8
One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.日本患者年龄相关性黄斑变性和息肉样脉络膜血管病变的光动力疗法一年期疗效
Ophthalmology. 2008 Jan;115(1):141-6. doi: 10.1016/j.ophtha.2007.02.031. Epub 2007 Jun 20.
9
Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.眼内注射贝伐单抗治疗息肉状脉络膜血管病变的渗出性分支血管网。
Br J Ophthalmol. 2012 Mar;96(3):394-9. doi: 10.1136/bjo.2011.204123. Epub 2011 Jun 30.
10
Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy.息肉状脉络膜血管病变光动力疗法的长期结果
Retina. 2008 May;28(5):717-22. doi: 10.1097/IAE.0b013e31816577cb.

引用本文的文献

1
Recurrence and visual prognostic factors of polypoidal choroidal vasculopathy: 5-year results.息肉样脉络膜血管病变的复发和视觉预后因素:5 年结果。
Sci Rep. 2021 Nov 3;11(1):21572. doi: 10.1038/s41598-021-00904-4.
2
Two-Thirds Dose Photodynamic Therapy for Pachychoroid Neovasculopathy.三分之二剂量光动力疗法治疗厚脉络膜新生血管病变
J Clin Med. 2021 May 17;10(10):2168. doi: 10.3390/jcm10102168.
3
Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices.特发性息肉状脉络膜血管病变:文献复习及现行治疗方法的临床更新。

本文引用的文献

1
Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area.光动力疗法对照射区域脉络膜毛细血管和视网膜色素上皮的影响。
Jpn J Ophthalmol. 2008 Jul-Aug;52(4):277-281. doi: 10.1007/s10384-008-0551-9. Epub 2008 Sep 5.
2
The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy.贝伐单抗对息肉状脉络膜血管病变患者的治疗效果。
Korean J Ophthalmol. 2008 Jun;22(2):92-9. doi: 10.3341/kjo.2008.22.2.92.
3
Clinicopathologic findings in polypoidal choroidal vasculopathy.
Int Ophthalmol. 2021 Feb;41(2):753-765. doi: 10.1007/s10792-020-01620-0. Epub 2020 Oct 20.
4
Polypoidal choroidal vasculopathy: An update on current management and review of literature.息肉样脉络膜血管病变:当前治疗进展及文献综述
Taiwan J Ophthalmol. 2019 Apr-Jun;9(2):72-92. doi: 10.4103/tjo.tjo_35_18.
5
Polypoidal choroidal vasculopathy: a comprehensive clinical update.息肉样脉络膜血管病变:临床综合进展
Ther Adv Ophthalmol. 2019 Feb 27;11:2515841419831152. doi: 10.1177/2515841419831152. eCollection 2019 Jan-Dec.
6
One-year outcomes of intravitreal conbercept combined rescue therapy for polypoidal choroidal vasculopathy in a Chinese population: a real-life clinical data.中国人群中玻璃体内注射康柏西普联合挽救疗法治疗息肉状脉络膜血管病变的一年期疗效:真实临床数据
Int J Ophthalmol. 2019 Jan 18;12(1):51-57. doi: 10.18240/ijo.2019.01.08. eCollection 2019.
7
Functional Polymer Nanocarriers for Photodynamic Therapy.用于光动力疗法的功能性聚合物纳米载体
Pharmaceuticals (Basel). 2018 Nov 30;11(4):133. doi: 10.3390/ph11040133.
8
Intravitreal ranibizumab injection combined with photodynamic therapy for polypoidal choroidal vasculopathy.玻璃体内注射雷珠单抗联合光动力疗法治疗息肉状脉络膜血管病变。
Exp Ther Med. 2018 Feb;15(2):1546-1551. doi: 10.3892/etm.2017.5565. Epub 2017 Nov 27.
9
Polypoidal Choroidal Vasculopathy.息肉样脉络膜血管病变
Curr Ophthalmol Rep. 2017 Jun;5(2):176-186. doi: 10.1007/s40135-017-0137-0. Epub 2017 Apr 21.
10
Clinical characteristics and antivascular endothelial growth factor effect of choroidal neovascularization in younger patients in Taiwan.台湾年轻患者脉络膜新生血管的临床特征及抗血管内皮生长因子效应
Taiwan J Ophthalmol. 2015 Apr-Jun;5(2):76-84. doi: 10.1016/j.tjo.2015.03.001. Epub 2015 Apr 24.
息肉状脉络膜血管病变的临床病理表现
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4729-37. doi: 10.1167/iovs.08-2134. Epub 2008 Jun 27.
4
Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy.光动力治疗后息肉状脉络膜血管病变的显著血管变化。
Br J Ophthalmol. 2008 Jul;92(7):936-40. doi: 10.1136/bjo.2007.132357.
5
Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy.息肉状脉络膜血管病变光动力疗法的长期结果
Retina. 2008 May;28(5):717-22. doi: 10.1097/IAE.0b013e31816577cb.
6
Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.用于治疗伴有息肉样脉络膜新生血管的新生血管性年龄相关性黄斑变性的选择性光动力疗法
Retina. 2007 Sep;27(7):825-31. doi: 10.1097/IAE.0b013e31804b3f70.
7
Role of photodynamic therapy in polypoidal choroidal vasculopathy.光动力疗法在息肉样脉络膜血管病变中的作用。
Jpn J Ophthalmol. 2007 Jul-Aug;51(4):270-7. doi: 10.1007/s10384-007-0452-3. Epub 2007 Aug 3.
8
One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.日本患者年龄相关性黄斑变性和息肉样脉络膜血管病变的光动力疗法一年期疗效
Ophthalmology. 2008 Jan;115(1):141-6. doi: 10.1016/j.ophtha.2007.02.031. Epub 2007 Jun 20.
9
Photodynamic therapy for age-related macular degeneration in Japanese patients: results after one year.日本患者年龄相关性黄斑变性的光动力疗法:一年后的结果
Jpn J Ophthalmol. 2007 May-Jun;51(3):210-5. doi: 10.1007/s10384-007-0436-3. Epub 2007 Jun 7.
10
Clinical characteristics of exudative age-related macular degeneration in Japanese patients.日本患者渗出性年龄相关性黄斑变性的临床特征
Am J Ophthalmol. 2007 Jul;144(1):15-22. doi: 10.1016/j.ajo.2007.03.047. Epub 2007 May 23.